ATE162714T1 - Zusammensetzungen und verfahren zur behandlung von autoimmunkrankheiten - Google Patents

Zusammensetzungen und verfahren zur behandlung von autoimmunkrankheiten

Info

Publication number: ATE162714T1
Authority: AT; Austria
Prior art keywords: image; treating autoimmune; compositions; methods; aliphatic
Prior art date: 1992-06-15

Application number

AT93916485T

Other languages

English (en)

Inventor

Stanislaw R Burzynski

Original Assignee

Stanislaw R Burzynski

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-06-15

Filing date

1993-06-10

Publication date

1998-02-15

1993-06-10 Application filed by Stanislaw R Burzynski filed Critical Stanislaw R Burzynski

1998-02-15 Application granted granted Critical

1998-02-15 Publication of ATE162714T1 publication Critical patent/ATE162714T1/de

Links

208000023275 Autoimmune disease Diseases 0.000 title abstract 2
239000000203 mixture Substances 0.000 title abstract 2
WLJVXDMOQOGPHL-PPJXEINESA-N 2-phenylacetic acid Chemical class O[14C](=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-PPJXEINESA-N 0.000 abstract 1
JFLIEFSWGNOPJJ-JTQLQIEISA-N N(2)-phenylacetyl-L-glutamine Chemical class NC(=O)CC[C@@H](C(O)=O)NC(=O)CC1=CC=CC=C1 JFLIEFSWGNOPJJ-JTQLQIEISA-N 0.000 abstract 1
206010067584 Type 1 diabetes mellitus Diseases 0.000 abstract 1
206010047115 Vasculitis Diseases 0.000 abstract 1
125000001931 aliphatic group Chemical group 0.000 abstract 1
125000003118 aryl group Chemical group 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
206010025135 lupus erythematosus Diseases 0.000 abstract 1
201000006417 multiple sclerosis Diseases 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
159000000000 sodium salts Chemical class 0.000 abstract 1
208000035408 type 1 diabetes mellitus 1 Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AT93916485T 1992-06-15 1993-06-10 Zusammensetzungen und verfahren zur behandlung von autoimmunkrankheiten ATE162714T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/898,295 US5646182A (en)	1992-06-15	1992-06-15	Methods for treating autoimmune diseases

Publications (1)

Publication Number	Publication Date
ATE162714T1 true ATE162714T1 (de)	1998-02-15

Family

ID=25409238

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT93916485T ATE162714T1 (de)	1992-06-15	1993-06-10	Zusammensetzungen und verfahren zur behandlung von autoimmunkrankheiten

Country Status (10)

Country	Link
US (1)	US5646182A (de)
EP (1)	EP0603383B1 (de)
AT (1)	ATE162714T1 (de)
AU (1)	AU656484B2 (de)
DE (1)	DE69316729T2 (de)
DK (1)	DK0603383T3 (de)
ES (1)	ES2115067T3 (de)
GR (1)	GR3026681T3 (de)
SG (1)	SG81891A1 (de)
WO (1)	WO1993025201A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6127419A (en) *	1998-11-23	2000-10-03	Burzynski; Stanislaw R.	Phenylacetic acid compositions for treating or preventing atherosclerosis and restenosis
SE521031C2 (sv) *	1999-05-05	2003-09-23	Srinivas Uppugunduri	Nya specifika inhibitorer av akut och kronisk inflammation
DK1313697T3 (da)	2000-08-29	2006-04-10	Nobex Corp	Immunregulatoriske forbindelser, derivater deraf samt anvendelse deraf
US8048924B2 (en)	2001-08-29	2011-11-01	Biocon Limited	Methods and compositions employing 4-aminophenylacetic acid compounds
DK1773767T3 (en)	2004-07-07	2016-03-21	Biocon Ltd	Synthesis of azo bound in immune regulatory relations
EP1890767A2 (de) *	2005-05-27	2008-02-27	Pfizer Products Inc.	Kombinationstherapie zur behandlung von fettleibigkeit oder aufrechterhaltung des gewichtverlusts

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH608785A5 (en) *	1975-04-30	1979-01-31	Science Union & Cie	Process for producing new N-acylglutamines
JPS53113032A (en) *	1977-03-09	1978-10-03	Mitsubishi Chem Ind Ltd	Immune depresants
US4438029A (en) *	1978-01-19	1984-03-20	Research Corporation	Synthetic peptides
JPS54160740A (en) *	1978-06-09	1979-12-19	Takeda Chem Ind Ltd	Anti-fibrotic agent
EP0052296B1 (de) *	1980-11-12	1984-06-27	Mitsubishi Kasei Corporation	Als Heilmittel für Immunokrankheiten anwendbare Glutaminderivate, Verfahren zu deren Herstellung und Zusammensetzungen, die die obengenannten Derivate enthalten
US4558057A (en) *	1981-12-15	1985-12-10	Burzynski Stanislaw R	Purified antineoplaston fractions and methods of treating neoplastic disease
US5098906A (en) *	1983-10-31	1992-03-24	Warner-Lambert Company	Purine derivatives
US4593038A (en) *	1985-04-03	1986-06-03	Burzynski Stanislaw R	Topical use of 3-phenylacetylamino-2,6-piperidinedione for treatment of skin wrinkles and hyperpigmentation
US5039704A (en) *	1985-09-12	1991-08-13	Brigham And Women's Hospital	Method of treating catabolic dysfunction
ATE54826T1 (de) *	1985-10-23	1990-08-15	Mulli Kurt Nachf Gmbh	Thymusextraktfraktionen enthaltende pharmazeutische zusammensetzung.
US4914112A (en) *	1986-06-03	1990-04-03	Sumitomo Pharmaceuticals Company, Limited	Aminoazole derivatives and their production and use
US5102883A (en) *	1989-10-31	1992-04-07	Du Pont Merck Pharmaceutical Company	Pyrimidine biosynthesis inhibitors useful as immunosuppressive agents
US5108999A (en) *	1990-02-02	1992-04-28	Syntex (U.S.A.) Inc.	4-isoxazolecarboxamide derivatives
US5089508A (en) *	1990-09-04	1992-02-18	Burzynski Stanislaw R	Methods for treating aids
US5244922A (en) *	1990-09-04	1993-09-14	Burzynski Stanislaw R	Methods for treating viral infections
US5116622A (en) *	1990-09-12	1992-05-26	Burzynski Stanislaw R	Methods for treating parkinson's disease

1992
- 1992-06-15 US US07/898,295 patent/US5646182A/en not_active Expired - Lifetime
1993
- 1993-06-10 DE DE69316729T patent/DE69316729T2/de not_active Expired - Fee Related
- 1993-06-10 DK DK93916485T patent/DK0603383T3/da active
- 1993-06-10 AU AU46319/93A patent/AU656484B2/en not_active Ceased
- 1993-06-10 ES ES93916485T patent/ES2115067T3/es not_active Expired - Lifetime
- 1993-06-10 SG SG9608395A patent/SG81891A1/en unknown
- 1993-06-10 EP EP93916485A patent/EP0603383B1/de not_active Expired - Lifetime
- 1993-06-10 AT AT93916485T patent/ATE162714T1/de not_active IP Right Cessation
- 1993-06-10 WO PCT/US1993/005555 patent/WO1993025201A1/en not_active Ceased
1998
- 1998-04-16 GR GR980400879T patent/GR3026681T3/el unknown

Also Published As

Publication number	Publication date
WO1993025201A1 (en)	1993-12-23
EP0603383A4 (de)	1994-12-21
DK0603383T3 (da)	1998-09-21
AU656484B2 (en)	1995-02-02
US5646182A (en)	1997-07-08
SG81891A1 (en)	2001-07-24
DE69316729T2 (de)	1998-08-06
ES2115067T3 (es)	1998-06-16
DE69316729D1 (de)	1998-03-05
EP0603383B1 (de)	1998-01-28
EP0603383A1 (de)	1994-06-29
GR3026681T3 (en)	1998-07-31
AU4631993A (en)	1994-01-04

Similar Documents

Publication	Publication Date	Title
ATE188871T1 (de)	2000-02-15	Verfahren zur behandlung von viralen infectionen
DE69206214D1 (de)	1996-01-04	Neue Arylethylaminderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.
KR960700708A (ko)	1996-02-24	3,4-디아릴크로만을 이용한 뼈 손실의 억제방법(methdos for inhibiting bone loss with 3,4-diarylchroman)
NO308792B1 (no)	2000-10-30	Derivater av valproinsyre og 2-valproensyreamider, farmasøytisk sammensetning derav og deres anvendelse for fremstilling av et farmasøytisk preparat
CA2015475A1 (en)	1990-10-28	Treating agent for osteoarthritis
ATE162714T1 (de)	1998-02-15	Zusammensetzungen und verfahren zur behandlung von autoimmunkrankheiten
IL93989A0 (en)	1991-01-31	Pharmaceutical compositions comprising heteroaryl-3-oxo-propanenitrile derivatives useful in the treatment of rheumatoid arthritis and other autoimmune diseases
HU9303000D0 (en)	1994-01-28	Aryl-morpholine-derivatives and pharmaceutical compositions containing it and process for production thereof
DE69220050D1 (de)	1997-07-03	Verfahren zur inhibierung der fibrose
ZA916977B (en)	1992-06-24	Pharmaceutical compositions for use in treating aids
ATE134363T1 (de)	1996-03-15	N-((4,5-dihydroxy- und 4,5,8-trihydroxy-9,10- dihydro-9,10-dioxo-2-anthracen- yl)carbonyl)aminosäure zur therapie osteoartikulärer leiden
EP0129891A3 (de)	1985-10-09	Chinazolinon-Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
EP0383481A3 (de)	1991-04-10	Bukkale Anästhetika
ATE59647T1 (de)	1991-01-15	Isoxazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutischen praeparate.
KR920008035A (ko)	1992-05-27	타이로신 유도체 및 그 제조방법
KR960703924A (ko)	1996-08-31	항바이러스제로서 신규한 벤조티오펜 유사체(Novel Benzothiophene Analogs as Antiviral Agents)
ES2005778A6 (es)	1989-03-16	Procedimiento para la obtencion de derivados de diisobutilxantina.
ZA939336B (en)	1994-08-25	New cephem compounds

Legal Events

Date	Code	Title	Description
1998-12-15	UEP	Publication of translation of european patent specification
2010-03-15	REN	Ceased due to non-payment of the annual fee